A sweeping analysis covers evidence of regression in autism, gender dysphoria is linked to autism features, and animal models of autism receive full treatment in a special tribute.
Spectrum: Autism Research News
Two new methods allow scientists to swap single bases in DNA or RNA sequences.
The agency that oversees the drug approval process in Europe is moving to Amsterdam, gene editing gets its first human trial, and a tiny sensor detects even a few oxytocin molecules in blood.
A new trick involving a virus gives the CRISPR enzyme system the ability to edit the genome of a neuron more predictably than was previously possible.
A novel method allows researchers to rapidly generate stem-cell colonies with mutations linked to autism or other conditions.
Two new gadgets join the gene-editing toolbox, many children with autism get smarter with age, and a survey points to a research reset for Autism Speaks.
Transcranial treatment may bolster memory in adults with autism, inflammatory molecule may alter an emotional brain region in newborns, and examining ants could yield insights into autism
Researchers in Oregon edit human embryos, prenatal antidepressants may play a role in autism risk, and gut microbiota are associated with early cognition.
A movement to ban valproate during pregnancy gains a foothold in France, people with auditory hallucinations seek to demedicalize the experience, and adults on the spectrum speak out.
Employers discover the perks of having staffers on the spectrum, robots deliver autism therapy, and Jennifer Doudna of CRISPR fame recounts her nightmares.